Topics

New biotech raises $57M to develop tumor-targeting cell therapies

04:44 EST 8 Nov 2019 | SmartBrief

A Series A funding round brought in $57 million for A2 Biotherapeutics, which recently named Scott Foraker president and CEO. -More

Original Article: New biotech raises $57M to develop tumor-targeting cell therapies

NEXT ARTICLE

More From BioPortfolio on "New biotech raises $57M to develop tumor-targeting cell therapies"

Quick Search

Relevant Topic

Biotherapeutics
The field encompassing therapeutic materials produced using biological means, including recombinant DNA technology. Biotherapeutics, also known as biotech drugs or biologics, are therapies derived from living organisms. By harnessing these living cells...